Sort
39,280 grants matching “leukemia”
Modulate Cullin-RING E3 ubiquitin ligases by small molecule agents
$702,771Zhen-Qiang Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Modulate Cullin-RING E3 ubiquitin ligases by small molecule agents
$702,771Zhen-Qiang Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Mechanism and functional consequences of dietary lipids in lineage specification and tumor growth in oncohistone gliomas
$702,459Nika N. Danial · Dana-Farber Cancer Inst · U01 · FY2025 · CA
Protein Arginine Methylation in Vascular Smooth Muscle Cell Phenotypic Modulation and Calcification
$702,421Yabing Chen · Oregon Health & Science University · R01 · FY2024 · HL
CCR Genomics Core
$702,309Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
$701,924Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Complex Human Diseases - From Gene to Function to Therapy
$701,821Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cancer and Inflammation - Genetics and Function
$701,821Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Center For Large-Scale Genome Sequencing & Analysis
$701,781Richard K. Wilson · Washington University · U54 · FY2008 · HG
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
$701,584Charles David Allis · Rockefeller University · R01 · FY2017 · CA
CD300 receptors regulate efferocytosis, importance in inflammation, cancer and autoimmunity
$701,557John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Promoting Treatment Adherence in Adolescent Leukemia
$701,307Dennis D Drotar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2007 · CA
Validation of Decision Rules for CT Use in Children with Abdominal or Head Trauma
$701,305James F Holmes · University Of California At Davis · R01 · FY2016 · HD
Tissue Core
$701,299Laura Z Rassenti · University Of California, San Diego · P01 · FY2007 · CA
TCR engineered T cell therapies for hematologic malignancies
$701,185Kazusa Ishii · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A compass for those with relapsed leukemia after transplant
$701,179Scott Nicholas Furlan · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression
$700,616Russell Christian Rockne · Beckman Research Institute/City Of Hope · U01 · FY2023 · CA
Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF
$700,288Naama Kanarek · Boston Children'S Hospital · R01 · FY2024 · CA
Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF
$700,288Naama Kanarek · Boston Children'S Hospital · R01 · FY2025 · CA
Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia
$700,050Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2022 · CA
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
$700,049Brian D Gonzalez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
$700,000Clara D Bloomfield · Ohio State University · U10 · FY2014 · CA
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
$700,000Robert Jon Soiffer · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Center for Integrative Research on Childhood Leukemia and the Environment
$700,000Catherine Metayer · University Of California Berkeley · P50 · FY2018 · ES
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
$700,000Robert Jon Soiffer · Dana-Farber Cancer Inst · R01 · FY2016 · CA